Biomedical Engineering Reference
In-Depth Information
43. Nielsen MK, Johansen SS (2009) Determination of olanzapine in whole blood using simple
protein precipitation and liquid chromatography-tandem mass spectrometry. J Anal Toxicol
33(4):212-217
44. Kollroser M, Schober C (2002) Direct-injection high performance liquid chromatography ion
trap mass spectrometry for the quantitative determination of olanzapine, clozapine and n-des-
methylclozapine in human plasma. Rapid Commun Mass Spectrom 16(13):1266-1272.
doi:
10.1002/rcm.718
45. Berna M, Shugert R, Mullen J (1998) Determination of olanzapine in human plasma and
serum by liquid chromatography/tandem mass spectrometry. J Mass Spectrom 33(10):1003-
1008. doi:10.1002/(SICI)1096-9888(1998100)33:10<1003::AID-JMS716>3.0.CO;2-P [pii]
10.1002/(SICI)1096-9888(1998100)33:10<1003::AID-JMS716>3.0.CO;2-P
46. Hasselstrom J (2011) Quantification of antidepressants and antipsychotics in human serum by
precipitation and ultra high pressure liquid chromatography-tandem mass spectrometry. J
Chromatogr B Analyt Technol Biomed Life Sci 879(1):123-128. doi
:
S1570-0232(10)00727-0
47. Moody DE, Laycock JD, Huang W, Foltz RL (2004) A high-performance liquid chromato-
graphic-atmospheric pressure chemical ionization-tandem mass spectrometric method for
determination of risperidone and 9-hydroxyrisperidone in human plasma. J Anal Toxicol
28(6):494-497
48. Berna M, Ackermann B, Ruterbories K, Glass S (2002) Determination of olanzapine in human
blood by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol
Biomed Life Sci 767(1):163-168
49. Dams R, Huestis MA, Lambert WE, Murphy CM (2003) Matrix effect in bio-analysis of illicit
drugs with lc-ms/ms: Influence of ionization type, sample preparation, and biofluid. J Am Soc
Mass Spectrom 14(11):1290-1294. doi:
S1044030503005749 [pii]
50. Bonfiglio R, King RC, Olah TV, Merkle K (1999) The effects of sample preparation
methods on the variability of the electrospray ionization response for model drug com-
pounds. Rapid Commun Mass Spectrom 13(12):1175-1185. doi:10.1002/(SICI)1097-
0231(19990630)13:12<1175::AID-RCM639>3.0.CO;2-0 [pii] 10.1002/(SICI)1097-0231
(19990630)13:12<1175::AID-RCM639>3.0.CO;2-0
51. Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of matrix
effect in quantitative bioanalytical methods based on hplc-ms/ms. Anal Chem 75(13):3019-3030
52. Maurer HH (2005) Advances in analytical toxicology: the current role of liquid chromatogra-
phy-mass spectrometry in drug quantification in blood and oral fluid. Anal Bioanal Chem
381(1):110-118. doi:
10.1007/s00216-004-2774-z
53. Cabovska B, Cox SL, Vinks AA (2007) Determination of risperidone and enantiomers of
9-hydroxyrisperidone in plasma by lc-ms/ms. J Chromatogr B Analyt Technol Biomed Life
Sci 852(1-2):497-504. doi:
S1570-0232(07)00105-5 [pii] 10.1016/j.jchromb.2007.02.007
54. Roman M, Kronstrand R, Lindstedt D, Josefsson M (2008) Quantitation of seven low-dosage
antipsychotic drugs in human postmortem blood using lc-ms-ms. J Anal Toxicol 32(2):147-155
55. Remane D, Meyer MR, Wissenbach DK, Maurer HH (2010) Ion suppression and enhancement
effects of co-eluting analytes in multi-analyte approaches: systematic investigation using ultra-
high-performance liquid chromatography/mass spectrometry with atmospheric-pressure
chemical ionization or electrospray ionization. Rapid Commun Mass Spectrom 24(21):3103-
3108. doi:
10.1002/rcm.4736
56. U.S. Department of Health and Human Services. Guidance for industry: mass spectrometry for
confirmation of the identity of animal drug residues, final guidance. Available at:
http://www.
htm
. Accessed 15 Jan 2012.
57. (WADA) TWA-DA (2010) Identification criteria for qualitative assays document td2003idcr
58. Union CotE (2002) Validation concepts for pesticide residues in food of animal origin
2002/657/ec
59. Peters FT, Maurer HH (2002) Bioanalytical method validation and its implications for forensic
and clinical toxicology - a review. Accred Qual Assur 7(11):441-449
